Grantham, Mayo, Van Otterloo & Co (GMO)’s Helen of Troy HELE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,002
Closed -$422K 780
2021
Q1
$422K Sell
2,002
-598
-23% -$135K ﹤0.01% 728
2020
Q4
$578K Sell
2,600
-800
-24% -$165K ﹤0.01% 660
2020
Q3
$658K Hold
3,400
﹤0.01% 586
2020
Q2
$641K Sell
3,400
-1,800
-35% -$295K ﹤0.01% 600
2020
Q1
$749K Sell
5,200
-1,800
-26% -$305K 0.01% 544
2019
Q4
$1.26M Sell
7,000
-500
-7% -$80.2K 0.01% 480
2019
Q3
$1.18M Sell
7,500
-104,800
-93% -$15.6M 0.01% 521
2019
Q2
$14.7M Sell
112,300
-108,200
-49% -$14.2M 0.1% 143
2019
Q1
$25.6M Buy
220,500
+195,800
+793% +$22.6M 0.18% 79
2018
Q4
$3.24M Buy
24,700
+5,700
+30% +$748K 0.03% 225
2018
Q3
$2.49M Buy
19,000
+15,800
+494% +$1.86M 0.02% 283
2018
Q2
$315K Buy
3,200
+300
+10% +$27.4K ﹤0.01% 503
2018
Q1
$252K Sell
2,900
-17,873
-86% -$1.63M ﹤0.01% 532
2017
Q4
$2M Sell
20,773
-9,200
-31% -$847K 0.01% 320
2017
Q3
$2.9M Sell
29,973
-5,700
-16% -$548K 0.02% 294
2017
Q2
$3.36M Sell
35,673
-11,915
-25% -$1.11M 0.02% 278
2017
Q1
$4.48M Sell
47,588
-113,555
-70% -$10.7M 0.03% 251
2016
Q4
$13.6M Sell
161,143
-182,843
-53% -$15.3M 0.07% 167
2016
Q3
$29.6M Sell
343,986
-131,002
-28% -$12.3M 0.14% 142
2016
Q2
$48.8M Buy
474,988
+129,273
+37% +$13M 0.2% 106
2016
Q1
$35.8M Buy
345,715
+258,000
+294% +$24.1M 0.13% 145
2015
Q4
$8.27M Buy
87,715
+13,600
+18% +$1.36M 0.03% 210
2015
Q3
$6.62M Buy
+74,115
New +$6.64M 0.02% 223
2014
Q1
Sell
-4,848
Closed -$240K 595
2013
Q4
$240K Buy
+4,848
New +$227K ﹤0.01% 647

Other funds holding HELE

Grantham, Mayo, Van Otterloo & Co (GMO)'s HELE Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Helen of Troy (HELE) in Q2 2021, closing a stake of 2,002 shares — an estimated $422K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HELE in Q4 2013 and held it in 24 quarters. The position peaked at $48.8M in Q2 2016. 287 funds tracked by Wall St. Rank hold HELE as of Q2 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Helen of Troy position as of Q2 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,002 Helen of Troy shares in Q2 2021, an estimated $422K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Helen of Troy in Q4 2013 and held it in 24 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Helen of Troy position peaked at $48.8M in Q2 2016.
  • 287 funds tracked by Wall St. Rank held Helen of Troy as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.